Truvada - AskMen
Links shared publicly online about this topic.
- 114total visits
Truvada - AskMen
View full resource at askmen.com
Tags: HIV, AIDS, HIV Medication, STD, Truvada
Most Recently Shared on July 28, 2011 at 12:52 pm By:
HIV Prevention Pill Receives FDA Panel Support
medicalnewstoday.com — “On Thursday, a panel of outside experts that advises the US Food and Drug Administration (FDA) voted to support approval of the daily pill Truvada to prevent HIV in healthy people.” View full resource at medicalnewstoday.com
Most Recently Shared on May 11, 2012 at 3:05 pm By:
MNT Drug Approvals Health News
HIV Prevention Pill Receives FDA Panel Support http://t.co/qePK7BRk #regulatory
AIDSmeds - Top Stories : Truvada Receives PrEP Approval Recommendation - by Tim Horn
aidsmeds.com — “In a series of votes by the U.S. Food and Drug Administration?s Antiviral Drugs Advisory Committee, Truvada (tenofovir plus emtricitabine) has been recommended for approval as the first prescription drug to prevent HIV among those at risk for the infection.” View full resource at aidsmeds.com
Most Recently Shared on May 11, 2012 at 1:06 pm By:
Updated: FDA committee recommends Truvada’s approval as PrEP | Science Speaks: HIV & TB News
sciencespeaksblog.org — “Updated: FDA committee recommends Truvada’s approval as PrEP | Science Speaks: HIV & TB News” View full resource at sciencespeaksblog.org
Most Recently Shared on May 11, 2012 at 12:41 pm By:
FDA committee recommends Truvada’s approval as PrEP http://t.co/ZWClu3Zs
F.D.A. Panel Backs Preventive Use of H.I.V. Drug Truvada - NYTimes.com
nytimes.com — “With 50,000 new H.I.V. cases each year in the United States, government advisers said Truvada, an antiviral medicine, should be approved for use in healthy people at high risk of infection.” View full resource at nytimes.com
Most Recently Shared on May 11, 2012 at 12:07 pm By:
elaine schattner Oncologist, Hematologist, Physician, Doctor, and Internist
FDA Advisory Panel Backs Preventive Use of HIV Drug - http://t.co/0ZD6U9HY
FDA panel backs Gilead's Truvada to prevent HIV - chicagotribune.com
healthcare.tweetmeme.com — “All the news on healthcare” View full resource at healthcare.tweetmeme.com
Most Recently Shared on May 11, 2012 at 3:52 am By:
Healthcare TweetMeme Health Social Media
FDA panel backs Gilead's Truvada to prevent HIV - http://t.co/lrSNYi9F http://t.co/kAjxU4gV (via @HIVDiscuss)
Panel recommends approving Truvada to prevent HIV infection - CNN.com
cnn.com — “A drug already approved for treatment of AIDS might one day be approved for prevention of the deadly disease in individuals at high risk.” View full resource at cnn.com
Most Recently Shared on May 11, 2012 at 2:10 am By:
Dr E Michael Weiss - HeartAndSoulDoc Doctor, Internist, Cardiologist, and Physician
Panel recommends approving Truvada to prevent HIV infection - http://t.co/FuPOwp3p http://t.co/9nDU8JIO
BBC News - HIV prevention pill Truvada backed by US experts
bbc.co.uk — “A panel of US health experts recommends formal approval of Truvada, a drug to prevent HIV infection in healthy people.” View full resource at bbc.co.uk
Most Recently Shared on May 11, 2012 at 1:22 am By:
US panel approves anti-HIV pill http://t.co/NfQrK7tM
Gilead’s Truvada Pill Is Safe for HIV Prevention - Bloomberg
bloomberg.com — “Gilead Sciences Inc.’s pill Truvada was safe and effective when used to protect uninfected people from getting HIV, U.S. regulators said in a report indicating the main concerns are when and how it should be used.” View full resource at bloomberg.com
Most Recently Shared on May 8, 2012 at 4:08 pm By:
Gilead’s Truvada Pill Is Safe for HIV Prevention, FDA Says http://t.co/hCJ9I44J via @BloombergNews
FDA Panel Weighs HIV Drug as Preventive Tool - WSJ.com
online.wsj.com — “A Food and Drug Administration panel will decide whether to recommend for the first time that certain healthy but at-risk people take a Gilead Sciences drug, Truvada, to help prevent them from contracting the virus that causes AIDS.” View full resource at online.wsj.com
Most Recently Shared on May 7, 2012 at 1:20 am By:
FDA Panel Considers HIV Drug for Prevention http://t.co/gYjJeX6u
Truvada As A Preventive Drug For Men At High Risk For HIV May Be Cost-Effective
medicalnewstoday.com — “A once-a-day pill to help prevent HIV infection could significantly reduce the spread of AIDS, but only makes economic sense if used in select, high-risk groups, Stanford University researchers co” View full resource at medicalnewstoday.com
Most Recently Shared on April 17, 2012 at 11:05 am By:
Truvada As A Preventive Drug For Men At High Risk For HIV May Be Cost-Effective http://t.co/Fww0UgwM #hivaids
AIDSmeds - Top Stories : Isentress Plus Truvada Is Safe, Potentially Effective as HIV PEP Regimen - by Tim Horn
aidsmeds.com — “Isentress (raltegravir) combined with Truvada (tenofovir plus emtricitabine) was extremely well tolerated as post-exposure prophylaxis (PEP) following high-risk sexual activity in a small study conducted by a team of researchers at Fenway Health in Boston.” View full resource at aidsmeds.com
Most Recently Shared on April 13, 2012 at 1:48 pm By:
Top Stories : Isentress Plus Truvada Is Safe, Potentially Effective as #HIV #PEP Regimen http://t.co/KndrfRAW #AIDS
AIDSmeds - Top Stories : GS 7340 Packs Greater HIV Punch, Potentially Better Safety, Versus Viread - by Tim Horn
aidsmeds.com — “A new formulation of the nucleotide reverse transcriptase inhibitor (NRTI) tenofovir, currently dubbed GS 7340, achieves superior efficacy along with far higher concentrations inside the cells targeted by HIV for infection, compared with the current version of tenofovir (found in Viread, Truvada and Atripla). These data, which were presented Wednesday, March 7, at the 19th Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, suggest that the drug may be an excellent candida” View full resource at aidsmeds.com
Most Recently Shared on March 15, 2012 at 10:20 pm By:
AIDSmeds - Top Stories : ‘Quad’ Comparable to Norvir-Reyataz Regimen in Phase III Study - by Tim Horn
aidsmeds.com — “A study of Gilead Sciences? Quad fixed-dose combination tablet containing the experimental integrase inhibitor elvitegravir and boosting agent cobicistat, along with tenofovir and emtricitabine, has met its primary objective, non-inferiority compared with the popular protease inhibitor-based regimen of Norvir (ritonavir)-boosted Reyataz (atazanavir) plus Truvada (tenofovir and emtricitabine), according to data presented Thursday, March 8, at the 19th Conference on Retroviruses and Opportunistic ” View full resource at aidsmeds.com
Most Recently Shared on March 13, 2012 at 9:10 pm By:
#CROI2012 : ‘Quad’ Comparable to Norvir-Reyataz Regimen in Phase III Study http://t.co/ndvybJtU #HIV #AIDS #CROI
Microsoft Word - 20055175-1409388-pi.doc
ofr.gov — “Microsoft Word - 20055175-1409388-pi.doc” View full resource at ofr.gov
Most Recently Shared on March 13, 2012 at 1:46 pm By:
eyeonfda Pharma and Health Lawyer
#FDA AdComm set 5/10 for Truvada sNDA for Pre-Exposure Prophylaxis - http://t.co/omUM6kVP #HIV
Priority Review Granted for Truvada for Reducing the Risk of Acquiring HIV Infection - MPR
empr.com — “Gilead Sciences announced that the FDA has accepted the supplemental New Drug Application (sNDA) and granted a six-month Priority Review for once-daily Truvada (emtricitabine/tenofovir disoproxil fumarate) for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection among uninfected adults.” View full resource at empr.com
Most Recently Shared on February 14, 2012 at 2:41 pm By:
Priority Review Granted for Truvada for Reducing the Risk of Acquiring #HIV Infection http://t.co/iYRssYtu #AIDS
Advertisement
